
RVMD Technical Analysis Summary (NASDAQ)
Analyze RVMD on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerRVMD Technical Analysis Summary (NASDAQ)
Revolution Medicines, Inc. (NASDAQ: RVMD) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Revolution Medicines, Inc. on the NASDAQ is awaiting a decisive move. Overall, Revolution Medicines, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 50.51
Stochastic %K: 56.53
Williams %R: -45.12
Rate of Change (ROC): -2.66
Takeaway:Revolution Medicines, Inc. shows neutral momentum, with indicators pointing to indecision.
MACD: -1.63
ADX: 20.20
ATR (14): 7.80
CCI (14): 41.37
Takeaway:Revolution Medicines, Inc. shows a firm trend supported by momentum, though one signal suggests caution.
Takeaway:Revolution Medicines, Inc. trades around the middle band, reflecting balanced price action.
Takeaway:Revolution Medicines, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:RVMD shows neutral money flow, with no clear directional pressure.
Bullish Signals
RSI above 50 → positive momentum from buyers.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
Overall Recommendation:Technical indicators for Revolution Medicines, Inc. are mixed, suggesting a Hold or wait-and-see approach.